|
|
|
By Abby Proch, executive editor for guest columns, Clinical Leader | At the recent SCOPE Summit, four experts in data management, monitoring, site operations, and tech weighed the pros and cons of adopting bring-your-own-device requirements for clinical trial eCOAs. | |
|
|
|
| Analyzing The FDA's Approach To Diversity In Clinical Trials | Article | By Hannah Kulkarni and Marc Wartenberger, CRIO | Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science. |
|
|
| Understanding The Importance Of Phase 4 Trials | Article | Castor | Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations. |
|
|
| Overcoming Issues Of Non-Enrolling Sites In Clinical Trials | White Paper | By Dave Hiltbrand and Dave Berry, PPD clinical research business of Thermo Fisher Scientific | Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues. |
|
|
|
|
|
|
.png){kind=logo}
